Search Page

1

Cite

Share

Research ethics for emerging trial designs: does equipoise need to adapt?

Hey SP, Weijer C, Taljaard M, Kesselheim AS. Hey SP, et al. Among authors: kesselheim as. BMJ. 2018 Jan 25;360:k226. doi: 10.1136/bmj.k226. BMJ. 2018. PMID: 29371211 No abstract available.

Cite

Share

2

Cite

Share

Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.

Kesselheim AS, Mello MM. Kesselheim AS, et al. Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483. Health Aff (Millwood). 2007. PMID: 17339677 Review.

Cite

Share

3

Cite

Share

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH. Kesselheim AS, et al. Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000. Drugs. 2010. PMID: 20329806 Free PMC article. Review.

Cite

Share

4

Cite

Share

Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literature.

Chokshi DA, Avorn J, Kesselheim AS. Chokshi DA, et al. Among authors: kesselheim as. Health Aff (Millwood). 2010 Oct;29(10):1842-8. doi: 10.1377/hlthaff.2010.0843. Health Aff (Millwood). 2010. PMID: 20921484

Cite

Share

5

Cite

Share

Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer.

Kesselheim AS, Myers JA, Avorn J. Kesselheim AS, et al. JAMA. 2011 Jun 8;305(22):2320-6. doi: 10.1001/jama.2011.769. JAMA. 2011. PMID: 21642684

Cite

Share

6

Cite

Share

Research ethics. Paying patients for their tissue: the legacy of Henrietta Lacks.

Truog RD, Kesselheim AS, Joffe S. Truog RD, et al. Among authors: kesselheim as. Science. 2012 Jul 6;337(6090):37-8. doi: 10.1126/science.1216888. Science. 2012. PMID: 22767914 Free PMC article. No abstract available.

Cite

Share

7

Cite

Share

Ethical considerations in orphan drug approval and use.

Kesselheim AS. Kesselheim AS. Clin Pharmacol Ther. 2012 Aug;92(2):153-5. doi: 10.1038/clpt.2012.92. Clin Pharmacol Ther. 2012. PMID: 22814660

Cite

Share

8

Cite

Share

Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures.

Kesselheim AS, Wang B, Studdert DM, Avorn J. Kesselheim AS, et al. PLoS Med. 2012;9(8):e1001280. doi: 10.1371/journal.pmed.1001280. Epub 2012 Aug 7. PLoS Med. 2012. PMID: 22899894 Free PMC article.

Cite

Share

9

Cite

Share

A randomized study of how physicians interpret research funding disclosures.

Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM, Glynn RJ, Joffe S, Avorn J. Kesselheim AS, et al. N Engl J Med. 2012 Sep 20;367(12):1119-27. doi: 10.1056/NEJMsa1202397. N Engl J Med. 2012. PMID: 22992075 Free PMC article.

Cite

Share

10

Cite

Share

Gene patenting--the Supreme Court finally speaks.

Kesselheim AS, Cook-Deegan RM, Winickoff DE, Mello MM. Kesselheim AS, et al. N Engl J Med. 2013 Aug 29;369(9):869-75. doi: 10.1056/NEJMhle1308199. Epub 2013 Jul 10. N Engl J Med. 2013. PMID: 23841703 Free PMC article. No abstract available.

Cite

Share